Investigation of Biological Activities of Wild Bitter Melon ( Linn. Var. Abbreviata Ser.)

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2019 Jun 2

PMID 31151277

Citations 5

Authors

Thi My Hanh Pham

Dai-Hung Ngo

Dai-Nghiep Ngo

Thanh Sang Vo

Affiliations

Soon will be listed here.

Abstract

Wild bitter melon ( L. var. Abbreviata Ser.) is a wild edible variety of , often used in folk medicine. In this study, the biological activities of its extract and fractions were investigated in vitro. It was found that ethyl acetate (EA) fraction exhibited high 1,1-diphenyl-2-picryl-hydrazyl (DPPH) scavenging activity with a half maximal inhibitory concentration (IC) value of 0.43 ± 0.04 mg/mL, while the chloroform (CF), EA, and n-butanol (Bu) fractions had strong 2,2-azinobis-3-ethyl benzothiazoline-6-sulfonic acid (ABTS) scavenging ability with IC values of 0.36 ± 0.04 mg/mL, 0.35 ± 0.02 mg/mL, and 0.35 ± 0.05 mg/mL, respectively. Moreover, the EA and Bu fractions exhibited the highest protective effect against HO-induced DNA damage in a concentration-dependent manner. Furthermore, the EA fraction was effective in the inhibition of enzyme α-amylase activity with an IC value of 0.27 ± 0.029 mg/mL. Finally, it was observed that the production of nitric oxide (NO), a pro-inflammatory mediator, was significantly reduced from LPS-stimulated murine macrophage RAW 264.7 cells by the ethanol extract (ET) and the EA fraction. Therefore, wild bitter melon could be considered as a promising biomaterial for the development of pharmaceutical products.

Citing Articles

Exploring the Mechanism of Asiatic Acid against Atherosclerosis Based on Molecular Docking, Molecular Dynamics, and Experimental Verification.

Wu Z, Yang L, Wang R, Yang J, Liang P, Ren W Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065817 PMC: 11279847. DOI: 10.3390/ph17070969.

Telomere-to-telomere genome assembly of bitter melon ( L. var. Ser.) reveals fruit development, composition and ripening genetic characteristics.

Fu A, Zheng Y, Guo J, Grierson D, Zhao X, Wen C Hortic Res. 2023; 10(1):uhac228.

PMID: 36643758 PMC: 9832870. DOI: 10.1093/hr/uhac228.

Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis.

Ho C, Huang J, Sun M, Tzeng I, Hsu Y, Kuo C Evid Based Complement Alternat Med. 2021; 2021:6671129.

PMID: 34239589 PMC: 8241502. DOI: 10.1155/2021/6671129.

Beneficial Impacts of Alpha-Eleostearic Acid from Wild Bitter Melon and Curcumin on Promotion of CDGSH Iron-Sulfur Domain 2: Therapeutic Roles in CNS Injuries and Diseases.

Kung W, Lin M Int J Mol Sci. 2021; 22(7).

PMID: 33804820 PMC: 8037269. DOI: 10.3390/ijms22073289.

A Review of Malaysian Herbal Plants and Their Active Constituents with Potential Therapeutic Applications in Sepsis.

Liew K, Hafiz M, Chong Y, Harith H, Israf D, Tham C Evid Based Complement Alternat Med. 2020; 2020:8257817.

PMID: 33193799 PMC: 7641701. DOI: 10.1155/2020/8257817.

References

Farnsworth N, Akerele O, Bingel A, Soejarto D, Guo Z . Medicinal plants in therapy. Bull World Health Organ. 1985; 63(6):965-81. PMC: 2536466. View

Tsai C, Chen E, Tsay H, Huang C . Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial. Nutr J. 2012; 11:4. PMC: 3311063. DOI: 10.1186/1475-2891-11-4. View

Hsiao C, Chen Y, Hsu Y, Huang C, Sung H, Chen S . Supplementation with Hualian No. 4 wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) extract increases anti-fatigue activities and enhances exercise performance in mice. J Vet Med Sci. 2017; 79(6):1110-1119. PMC: 5487792. DOI: 10.1292/jvms.17-0079. View

Chen J, Liu W, Lu L, Qiu M, Zheng Y, Yang L . Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia. Phytochemistry. 2008; 70(1):133-40. DOI: 10.1016/j.phytochem.2008.10.011. View

Mishra B, Tiwari V . Natural products: an evolving role in future drug discovery. Eur J Med Chem. 2011; 46(10):4769-807. DOI: 10.1016/j.ejmech.2011.07.057. View

Sharma J, Al-Omran A, Parvathy S . Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2008; 15(6):252-9. DOI: 10.1007/s10787-007-0013-x. View

Virdi J, Sivakami S, Shahani S, Suthar A, Banavalikar M, Biyani M . Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol. 2003; 88(1):107-11. DOI: 10.1016/s0378-8741(03)00184-3. View

Aljohi A, Matou-Nasri S, Ahmed N . Antiglycation and Antioxidant Properties of Momordica charantia. PLoS One. 2016; 11(8):e0159985. PMC: 4981456. DOI: 10.1371/journal.pone.0159985. View

Poovitha S, Parani M . In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement Altern Med. 2016; 16 Suppl 1:185. PMC: 4959359. DOI: 10.1186/s12906-016-1085-1. View

10.

Ngo D, Vo T, Ngo D, Wijesekara I, Kim S . Biological activities and potential health benefits of bioactive peptides derived from marine organisms. Int J Biol Macromol. 2012; 51(4):378-83. DOI: 10.1016/j.ijbiomac.2012.06.001. View

11.

Vo T, Ngo D, Van Ta Q, Wijesekara I, Kong C, Kim S . Protective effect of chitin oligosaccharides against lipopolysaccharide-induced inflammatory response in BV-2 microglia. Cell Immunol. 2012; 277(1-2):14-21. DOI: 10.1016/j.cellimm.2012.06.005. View

12.

Hsu C, Tsai T, Li Y, Wu W, Huang C, Tsai P . Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation. Food Chem. 2012; 135(3):976-84. DOI: 10.1016/j.foodchem.2012.05.045. View

13.

Yin R, Lee N, Hirpara H, Phung O . The effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: a systematic review and meta-analysis. Nutr Diabetes. 2014; 4:e145. PMC: 4315906. DOI: 10.1038/nutd.2014.42. View

14.

Tan H, Gan C . Polysaccharide with antioxidant, α-amylase inhibitory and ACE inhibitory activities from Momordica charantia. Int J Biol Macromol. 2016; 85:487-96. DOI: 10.1016/j.ijbiomac.2016.01.023. View

15.

Rehman K, Chohan T, Waheed I, Gilani Z, Akash M . Taxifolin prevents postprandial hyperglycemia by regulating the activity of α-amylase: Evidence from an in vivo and in silico studies. J Cell Biochem. 2018; 120(1):425-438. DOI: 10.1002/jcb.27398. View

16.

Jia S, Shen M, Zhang F, Xie J . Recent Advances in Momordica charantia: Functional Components and Biological Activities. Int J Mol Sci. 2017; 18(12). PMC: 5751158. DOI: 10.3390/ijms18122555. View

17.

Lu K, Tseng H, Liu C, Huang C, Chyuan J, Sheen L . Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses. Food Funct. 2014; 5(5):1027-37. DOI: 10.1039/c3fo60449g. View

18.

Han C, Hui Q, Wang Y . Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems. Nat Prod Res. 2008; 22(13):1112-9. DOI: 10.1080/14786410802079675. View

19.

Vo T, Ngo D, Kim J, Ryu B, Kim S . An antihypertensive peptide from tilapia gelatin diminishes free radical formation in murine microglial cells. J Agric Food Chem. 2011; 59(22):12193-7. DOI: 10.1021/jf202837g. View

20.

Zhao G, Liu J, Deng Y, Li H, Chen J, Zhang Z . Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantia. Fitoterapia. 2014; 95:75-82. DOI: 10.1016/j.fitote.2014.03.005. View